{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:01:47Z","timestamp":1793325707004,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.critrevonc.2009.03.012","type":"journal-article","created":{"date-parts":[[2009,4,29]],"date-time":"2009-04-29T05:34:38Z","timestamp":1240983278000},"page":"213-219","source":"Crossref","is-referenced-by-count":41,"title":["Electrolyte disorders related to EGFR-targeting drugs"],"prefix":"10.1016","volume":"73","author":[{"given":"Hassane","family":"Izzedine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rastilav","family":"Bahleda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Khayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Massard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Magn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Philippe","family":"Spano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Charles","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2009.03.012_bib1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.ajkd.2007.04.025","article-title":"Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertension","volume":"50","author":"Izzedine","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib3","first-page":"764","article-title":"Immunohistochemical study of epidermal growth factor receptor (EGFR) in various types of renal injury","volume":"9","author":"Nakopoulou","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib4","doi-asserted-by":"crossref","first-page":"F599","DOI":"10.1152\/ajprenal.00312.2003","article-title":"Insights into the molecular nature of magnesium homeostasis","volume":"286","author":"Konrad","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib5","first-page":"1311","article-title":"Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model","volume":"1","author":"Goldstein","year":"1995","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib6","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1073\/pnas.80.5.1337","article-title":"Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody","volume":"80","author":"Kawamoto","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib7","first-page":"511","article-title":"Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors","volume":"1","author":"Sato","year":"1983","journal-title":"Mol Biol Med"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib8","first-page":"4322","article-title":"Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies","volume":"53","author":"Fan","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib9","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/dji242","article-title":"Cetuximab therapy and symptomatic hypomagnesemia","volume":"97","author":"Schrag","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3816\/CCC.2006.n.033","article-title":"Cetuximab-induced hypomagnesemia in patients with colorectal cancer","volume":"6","author":"Fakih","year":"2006","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib11","unstructured":"Erbitux package insert. March 2006. ImClone Systems Incorporated, New York, NY 10014, USA, and Bristol-Myers Squibb Company, Princeton, NY 08543, USA."},{"key":"10.1016\/j.critrevonc.2009.03.012_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(07)70108-0","article-title":"Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study","volume":"8","author":"Tejpar","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib13","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa071834","article-title":"Cetuximab for the treatment of colorectal cancer","volume":"357","author":"Jonker","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib14","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1200\/JCO.2006.08.1620","article-title":"Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer","volume":"25","author":"Van Cutsem","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib15","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/jnci\/dji412","article-title":"Re: Cetuximab therapy and symptomatic hypomagnesemia","volume":"97","author":"Altundag","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1152\/physrev.2001.81.1.51","article-title":"Magnesium transport in the renal distal convoluted tubule","volume":"81","author":"Dai","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1677\/joe.0.1130117","article-title":"Comparison of the feedback effect of magnesium and calcium on parathyroid hormone secretion in man","volume":"113","author":"Ferment","year":"1987","journal-title":"J Endocrinol"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib18","doi-asserted-by":"crossref","unstructured":"Cholst IN, Steinberg SF, Tropper PJ, Fox HE, Segre GV, Bilezikian JP. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 310:1221\u20131225.","DOI":"10.1056\/NEJM198405103101904"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1681\/ASN.2004070523","article-title":"Epithelial Ca2+ and Mg2+ channels in health and disease","volume":"16","author":"Hoenderop","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib20","first-page":"F393","article-title":"Magnesium transport in the nephron","volume":"239","author":"Quamme","year":"1980","journal-title":"Am J Physiol"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib21","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ki.1997.443","article-title":"Renal magnesium handling: new insights in understanding old problems","volume":"52","author":"Quamme","year":"1997","journal-title":"Kidney Int"},{"issue":"5424","key":"10.1016\/j.critrevonc.2009.03.012_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.285.5424.103","article-title":"Paracellin-1, a renal tight junction protein required for paracellular Mg2+ resorption","volume":"285","author":"Simon","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/ddl020","article-title":"Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: blocking endocytosis restores surface expression of a novel claudin-16 mutant that lacks the entire C-terminal cytosolic tail","volume":"15","author":"M\u00fcller","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1086\/508617","article-title":"Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement","volume":"79","author":"Konrad","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib25","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1172\/JCI31680","article-title":"Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia","volume":"117","author":"Groenestege","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib26","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/34.9.2426343","article-title":"Immunocytochemical localization of epidermal growth factor in mouse kidney","volume":"34","author":"Salido","year":"1986","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ki.1996.94","article-title":"Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study","volume":"49","author":"Gesualdo","year":"1996","journal-title":"Kidney Int"},{"issue":"5999","key":"10.1016\/j.critrevonc.2009.03.012_bib28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/313228a0","article-title":"Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues","volume":"313","author":"Rall","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib29","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1093\/nar\/14.21.8427","article-title":"Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization","volume":"14","author":"Bell","year":"1986","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1074\/jbc.M311201200","article-title":"TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption","volume":"279","author":"Voets","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng901","article-title":"Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia","volume":"31","author":"Walder","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib32","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1046\/j.1523-1755.2001.00736.x","article-title":"Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle","volume":"59","author":"Blanchard","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib33","first-page":"74","article-title":"Management of anti-EGFR-targeting monoclonal antibody-induced hypomagnesemia","volume":"22","author":"Fakih","year":"2008","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.0954-6820.1983.tb08598.x","article-title":"Severe hypophosphatemia\u2014a hospital survey","volume":"214","author":"Larsson","year":"1983","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/00007611-198707000-00008","article-title":"Severe hypophosphatemia in a general hospital population","volume":"80","author":"King","year":"1987","journal-title":"South Med J"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib36","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.amjmed.2005.02.014","article-title":"Hypophosphatemia: an update on its etiology and treatment","volume":"118","author":"Gaasbeek","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archinte.148.1.153","article-title":"Severe hypophosphatemia in hospitalized patients","volume":"148","author":"Halevy","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200001000-00001","article-title":"Severe hypophosphatemia. Pathophysiologic implications, clinical presentations, and treatment","volume":"79","author":"Subramanian","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.pharmtox.43.100901.135813","article-title":"Signal transduction-directed cancer treatments","volume":"43","author":"Sausville","year":"2003","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib40","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1200\/JCO.2005.03.6723","article-title":"Phase II placebo-controlled randomized discontinuation trial of sorafenib in patientswith metastatic renal cell carcinoma","volume":"24","author":"Ratain","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"TARGET Study Group. Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2009.03.012_bib42","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/cncr.23902","article-title":"Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study","volume":"113","author":"Belani","year":"2008","journal-title":"Cancer"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842809000778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842809000778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T15:05:23Z","timestamp":1558278323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842809000778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1040842809000778"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2009.03.012","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}